(European Molecular Biology Laboratory) The Wellcome Trust has awarded £4.7 million to EMBL's European Bioinformatics Institute to support the transfer of a large collection of information on the properties and activities of drugs and a large set of drug-like small molecules from publicly listed company Galapagos NV to the public domain.